z-logo
Premium
SULT1A1 polymorphism and esophageal cancer in males
Author(s) -
Wu MingTsang,
Wang YiTing,
Ho ChiKung,
Wu DengChyang,
Lee YungChie,
Hsu HonKi,
Kao EinLong,
Lee JangMing
Publication year - 2002
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.10805
Subject(s) - esophageal cancer , areca , genotype , medicine , allele , gastroenterology , alcohol consumption , carcinoma , cancer , oncology , alcohol , genetics , biology , gene , biochemistry , structural engineering , nut , engineering
Sulfotransferase (SULT) 1A1 detoxifies and bioactivates a broad spectrum of substrates including xenobiotics. It has been suggested that the SULT1A1 his ( histidine ) allele, which is caused by a his for arg ( arginine ) substitution due to a G→A transition at codon 213, carries a significantly higher risk for women to develop breast cancer. We investigated the association between the SULT1A1 arg / his genotype and esophageal cancer in men, 187 cases of esophageal squamous cell carcinoma and 308 controls from 3 medical centers in Taiwan. Cigarette smoking, areca chewing and alcohol consumption were the major risks for developing esophageal cancer. The frequencies of arg / his in cases and controls were 27.8% (52/187) and 11.0% (34/308), respectively ( p < 0.0001). No subjects carried his / his . After adjusting for substance use and other covariates, individuals with arg / his had a 3.53‐fold higher risk (95% CI = 2.12–5.87) of developing esophageal cancer than those with arg / arg . Unexpectedly, this positive association was found to be even stronger (adjusted OR = 4.04–4.80) among non‐smokers, non‐drinkers or non‐chewers. Our findings suggest that the SULT1A1 his 213 allele is important in the development of esophageal cancer in men. © 2002 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom